| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
In the last three months, 14 analysts have published ratings on Olin (NYSE:OLN), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 1 | 11 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 1 | 3 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 7 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $23.71, a high estimate of $32.00, and a low estimate of $20.00. Observing a downward trend, the current average is 9.3% lower than the prior average price target of $26.14.
The standing of Olin among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Roberts | Mizuho | Lowers | Neutral | $23.00 | $24.00 |
| John Roberts | Mizuho | Lowers | Neutral | $24.00 | $25.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $32.00 | $34.00 |
| Joshua Spector | UBS | Raises | Neutral | $23.00 | $22.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $25.00 | $26.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $23.00 | $25.00 |
| Michael Leithead | Barclays | Lowers | Equal-Weight | $24.00 | $28.00 |
| Angel Castillo | Morgan Stanley | Lowers | Underweight | $20.00 | $28.00 |
| Duffy Fischer | Goldman Sachs | Lowers | Neutral | $25.00 | $33.00 |
| Jeffrey Zekauskas | JP Morgan | Lowers | Neutral | $20.00 | $28.00 |
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $22.00 | $19.00 |
| Peter Osterland | Truist Securities | Lowers | Hold | $24.00 | $25.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $25.00 | $28.00 |
| Joshua Spector | UBS | Raises | Neutral | $22.00 | $21.00 |
To gain a panoramic view of Olin's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Olin analyst ratings.
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Olin's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.54% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Olin's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.07%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Olin's ROE excels beyond industry benchmarks, reaching 0.06%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Olin's ROA stands out, surpassing industry averages. With an impressive ROA of 0.02%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 1.66, Olin faces challenges in effectively managing its debt levels, indicating potential financial strain.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: OLN
